Literature DB >> 31588393

Mushrooms: an emerging resource for therapeutic terpenoids.

Adhiraj Dasgupta1, Krishnendu Acharya1.   

Abstract

Mankind has always been fascinated with nature and have heavily explored natural products since the ancient times. Evolution of diseases led to research on synthetic structure, specificity and activity-guided treatment. To combat threats of new developing diseases and the deleterious side effects posed by modern therapy, researchers have once again looked back towards natural resources. Although plants have been the main source of natural drugs, lower fungi are being recently paid attention to. Among them, mushrooms have emerged as an under-explored yet immensely rich resource, especially for bioactive terpenoids. A lot of research is going on around the world with mushroom-derived terpenoids especially their medicinal properties, some of which have even been used in pre- and post-clinical studies. From the literatures that are available, it was found that mushroom terpenoids have activity against a wide range of diseases. In this review, we have summarized different mushroom-derived terpenoids and their therapeutic properties. © King Abdulaziz City for Science and Technology 2019.

Entities:  

Keywords:  Diseases; Medicinal mushroom; Natural product; Secondary metabolites

Year:  2019        PMID: 31588393      PMCID: PMC6760460          DOI: 10.1007/s13205-019-1906-2

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  109 in total

Review 1.  Antrodia cinnamomea-An updated minireview of its bioactive components and biological activity.

Authors:  Nagarajan Ganesan; Rathinasamy Baskaran; Bharath Kumar Velmurugan; Nguyen Chi Thanh
Journal:  J Food Biochem       Date:  2019-06-04       Impact factor: 2.720

Review 2.  Role of free radicals and catalytic metal ions in human disease: an overview.

Authors:  B Halliwell; J M Gutteridge
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 3.  Production of bioactive metabolites by submerged fermentation of the medicinal mushroom Antrodia cinnamomea: recent advances and future development.

Authors:  Bo-Bo Zhang; Yu-Yan Guan; Peng-Fei Hu; Lei Chen; Gan-Rong Xu; Liming Liu; Peter C K Cheung
Journal:  Crit Rev Biotechnol       Date:  2019-02-27       Impact factor: 8.429

4.  In vitro activity of hypnophilin from Lentinus strigosus: a potential prototype for Chagas disease and leishmaniasis chemotherapy.

Authors:  E M Souza-Fagundes; B B Cota; L H Rosa; A J Romanha; R Corrêa-Oliveira; C A Rosa; C L Zani; A Teixeira-Carvalho; O A Martins-Filho
Journal:  Braz J Med Biol Res       Date:  2010-10-14       Impact factor: 2.590

Review 5.  Ganoderma - a therapeutic fungal biofactory.

Authors:  R Russell M Paterson
Journal:  Phytochemistry       Date:  2006-08-14       Impact factor: 4.072

Review 6.  Classification and basic pathology of Alzheimer disease.

Authors:  Charles Duyckaerts; Benoît Delatour; Marie-Claude Potier
Journal:  Acta Neuropathol       Date:  2009-04-21       Impact factor: 17.088

7.  Antibacterial compounds from mushrooms II: lanostane triterpenoids and an ergostane steroid with activity against Bacillus cereus isolated from Fomitopsis pinicola.

Authors:  Xue-Ting Liu; Abby L Winkler; William R Schwan; Thomas J Volk; Marc Rott; Aaron Monte
Journal:  Planta Med       Date:  2009-10-21       Impact factor: 3.352

8.  Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient.

Authors:  Basu Dev Pandey; Kishor Pandey; Osamu Kaneko; Tetsuo Yanagi; Kenji Hirayama
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

9.  A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors.

Authors:  Jérôme Alexandre; Carmen Kahatt; Frédérique Bertheault-Cvitkovic; Sandrine Faivre; Stephen Shibata; Werner Hilgers; François Goldwasser; François Lokiec; Eric Raymond; Garry Weems; Ajit Shah; John R MacDonald; Esteban Cvitkovic
Journal:  Invest New Drugs       Date:  2007-07-13       Impact factor: 3.850

Review 10.  Terpenoids as potential anti-Alzheimer's disease therapeutics.

Authors:  Ki-Yeol Yoo; So-Young Park
Journal:  Molecules       Date:  2012-03-19       Impact factor: 4.411

View more
  5 in total

Review 1.  Mycomedicine: A Unique Class of Natural Products with Potent Anti-tumour Bioactivities.

Authors:  Rongchen Dai; Mengfan Liu; Wan Najbah Nik Nabil; Zhichao Xi; Hongxi Xu
Journal:  Molecules       Date:  2021-02-19       Impact factor: 4.411

2.  Two New Triterpenes from Basidiomata of the Medicinal and Edible Mushroom, Laetiporus sulphureus.

Authors:  Khadija Hassan; Blondelle Matio Kemkuignou; Marc Stadler
Journal:  Molecules       Date:  2021-11-24       Impact factor: 4.411

Review 3.  Medicinal Components in Edible Mushrooms on Diabetes Mellitus Treatment.

Authors:  Arpita Das; Chiao-Ming Chen; Shu-Chi Mu; Shu-Hui Yang; Yu-Ming Ju; Sing-Chung Li
Journal:  Pharmaceutics       Date:  2022-02-17       Impact factor: 6.321

Review 4.  Mushrooms as Potential Sources of Active Metabolites and Medicines.

Authors:  Anne Bhambri; Malay Srivastava; Vivek G Mahale; Sushma Mahale; Santosh Kumar Karn
Journal:  Front Microbiol       Date:  2022-04-26       Impact factor: 6.064

5.  Survival of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Herpes Simplex Virus 1 (HSV-1) on Foods Stored at Refrigerated Temperature.

Authors:  Janak Dhakal; Mo Jia; Jonathan D Joyce; Greyson A Moore; Reza Ovissipour; Andrea S Bertke
Journal:  Foods       Date:  2021-05-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.